BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3162684)

  • 1. A phorbol ester tolerant (PET) variant of HL-60 promyelocytes.
    Macfarlane DE; Gailani D; Vann K
    Br J Haematol; 1988 Mar; 68(3):291-302. PubMed ID: 3162684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of phorbol ester-induced down-regulation of myc protein in the phorbol ester-tolerant mutant of HL-60 promyelocytes.
    Gailani D; Cadwell FJ; O'Donnell PS; Hromas RA; Macfarlane DE
    Cancer Res; 1989 Oct; 49(19):5329-33. PubMed ID: 2670202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phorbol ester induces apoptosis in HL-60 promyelocytic leukemia cells but not in HL-60 PET mutant.
    Macfarlane DE; O'Donnell PS
    Leukemia; 1993 Nov; 7(11):1846-51. PubMed ID: 8231252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid promotes phorbol ester-initiated macrophage differentiation in HL-60 leukemia cells without disappearance of protein kinase C.
    Zylber-Katz E; Knode MC; Glazer RI
    Leuk Res; 1986; 10(12):1425-32. PubMed ID: 3099098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of beta-isozyme of protein kinase C (PKC beta) is necessary and sufficient for phorbol ester-induced differentiation of HL-60 promyelocytes. Studies with PKC beta-defective PET mutant.
    Macfarlane DE; Manzel L
    J Biol Chem; 1994 Feb; 269(6):4327-31. PubMed ID: 8308000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
    Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E
    Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All-trans retinoic acid reverses phorbol ester resistance in a human myeloid leukemia cell line.
    Yang KD; Mizobuchi T; Kharbanda SM; Datta R; Huberman E; Kufe DW; Stone RM
    Blood; 1994 Jan; 83(2):490-6. PubMed ID: 8286746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of human promyelocytic leukemia cell (HL60) variants insensitive to phorbol ester tumor promoters.
    Mascioli DW; Estensen RD
    Cancer Res; 1984 Aug; 44(8):3280-5. PubMed ID: 6331641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis of human leukemic HL-60 cells induced to differentiate by phorbol ester treatment.
    Solary E; Bertrand R; Pommier Y
    Leukemia; 1994 May; 8(5):792-7. PubMed ID: 8182936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation and dephosphorylation of human promyelocytic leukemia cell (HL-60) proteins by tumor promoter.
    Mita S; Nakaki T; Yamamoto S; Kato R
    Exp Cell Res; 1984 Oct; 154(2):492-9. PubMed ID: 6592101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingomyelinase action inhibits phorbol ester-induced differentiation of human promyelocytic leukemic (HL-60) cells.
    Kolesnick RN
    J Biol Chem; 1989 May; 264(13):7617-23. PubMed ID: 2540198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of lithium on the growth and phorbol ester (TPA) induced differentiation of two HL-60 sublines.
    Masemola AM; Becker RW; Tyobeka EM
    Leuk Res; 1991; 15(8):727-32. PubMed ID: 1895753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phorbol diester-induced phosphorylation of nuclear matrix proteins in HL60 promyelocytes. Possible role in differentiation studied by cationic detergent gel electrophoresis.
    Macfarlane DE
    J Biol Chem; 1986 May; 261(15):6947-53. PubMed ID: 3457795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of TPA-induced growth inhibition and apoptosis in myeloid leukemia cells by BAY 11-7082, an NF-kappaB inhibitor.
    Hansson A; MarĂ­n YE; Suh J; Rabson AB; Chen S; Huberman E; Chang RL; Conney AH; Zheng X
    Int J Oncol; 2005 Oct; 27(4):941-8. PubMed ID: 16142309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HL-60 cell differentiation induced by phorbol- and 12-deoxyphorbol-esters.
    Ryves WJ; Dimitrijevic S; Gordge PC; Evans FJ
    Carcinogenesis; 1994 Nov; 15(11):2501-6. PubMed ID: 7955099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of phorbol ester-induced phenotypic differentiation of HL-60 cells by 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine, a protein kinase inhibitor.
    Matsui T; Nakao Y; Koizumi T; Katakami Y; Fujita T
    Cancer Res; 1986 Feb; 46(2):583-7. PubMed ID: 3606750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of protein kinase C activation from phorbol ester-induced maturation of HL-60 leukemia cells.
    Kreutter D; Caldwell AB; Morin MJ
    J Biol Chem; 1985 May; 260(10):5979-84. PubMed ID: 2987211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of protein kinase C in phosphorylation of vinculin in adriamycin-resistant HL-60 leukemia cells.
    Aquino A; Hartman KD; Knode MC; Grant S; Huang KP; Niu CH; Glazer RI
    Cancer Res; 1988 Jun; 48(12):3324-9. PubMed ID: 3130982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of type II protein kinase C in HL-60 variant cells resistant to induction of cell differentiation by phorbol diester.
    Nishikawa M; Komada F; Uemura Y; Hidaka H; Shirakawa S
    Cancer Res; 1990 Feb; 50(3):621-6. PubMed ID: 2297701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the differentiation of promyelocytic cells by phorbol ester. II. A methylation inhibitor, 3-deazaadenosine, inhibits the induction of specific differentiation proteins. Lack of effect on early and late phosphorylation events.
    Feuerstein N; Cooper HL
    Biochim Biophys Acta; 1984 Apr; 781(3):247-56. PubMed ID: 6584181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.